Cargando…

Improving radiotherapy in cancer treatment: Promises and challenges

Effective radiotherapy for cancer has relied on the promise of maximally eradicating tumor cells while minimally killing normal cells. Technological advancement has provided state-of-the-art instrumentation that enables delivery of radiotherapy with great precision to tumor lesions with substantial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Helen H.W., Kuo, Macus Tien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617545/ https://www.ncbi.nlm.nih.gov/pubmed/28977985 http://dx.doi.org/10.18632/oncotarget.18409

Ejemplares similares

Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy
por: Kuo, Macus Tien, et al.
Publicado: (2021)

Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy
por: Chen, Helen H. W., et al.
Publicado: (2010)

Targeting the Proline–Glutamine–Asparagine–Arginine Metabolic Axis in Amino Acid Starvation Cancer Therapy
por: Kuo, Macus Tien, et al.
Publicado: (2021)

Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis
por: Lai, Yu-Hsuan, et al.
Publicado: (2018)

Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes
por: Kuo, Macus Tien, et al.
Publicado: (2010)

Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors
por: Kuo, Macus Tien, et al.
Publicado: (2019)

The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment
por: Haque, Munima, et al.
Publicado: (2023)

C‐Jun N‐terminal kinase signalling pathway in response to cisplatin
por: Yan, Dong, et al.
Publicado: (2016)

Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation
por: Long, Yan, et al.
Publicado: (2016)

Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals
por: Liang, Zheng Dong, et al.
Publicado: (2013)

FLASH radiotherapy: A promising new method for radiotherapy
por: Lv, Yinghao, et al.
Publicado: (2022)

A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

Gas6/Axl in arginine-starvation therapy
por: Tsai, Wen-Bin, et al.
Publicado: (2015)

Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges
por: Prieto-Dominguez, Néstor, et al.
Publicado: (2019)

The promise and challenge of cancer microbiome research
por: Manzoor, Sumeed Syed, et al.
Publicado: (2020)

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
por: Olivares-Urbano, María Auxiliadora, et al.
Publicado: (2020)

Global challenges of radiotherapy for the treatment of locally advanced cervical cancer
por: Mayadev, Jyoti S, et al.
Publicado: (2022)

Promises and challenges in pharmacoepigenetics
por: Smith, Delaney A., et al.
Publicado: (2023)

Molecular Classifiers in Skin Cancers: Challenges and Promises
por: Azimi, Ali, et al.
Publicado: (2023)

p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis
por: Guan, Xiaoxiang, et al.
Publicado: (2010)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression
por: Tsai, Wen-Bin, et al.
Publicado: (2017)

Vestibular assistance systems: promises and challenges
por: Guyot, Jean-Philippe, et al.
Publicado: (2016)

Targeting cancer with antibody-drug conjugates: Promises and challenges
por: Dean, Alexis Q., et al.
Publicado: (2021)

Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises
por: Ahmad, Faraz, et al.
Publicado: (2022)

The Leukemic Fly: Promises and Challenges
por: Al Outa, Amani, et al.
Publicado: (2020)

Edible Vaccines: Promises and Challenges
por: Kurup, Vrinda M, et al.
Publicado: (2019)

Is Aducanumab for LMICs? Promises and Challenges
por: Gunawardena, Illangage P. C., et al.
Publicado: (2021)

TRPA1 as a drug target—promise and challenges
por: Chen, Jun, et al.
Publicado: (2015)

Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments †
por: Arbabi-Ghahroudi, Mehdi
Publicado: (2022)

Total Skin Treatment with Helical Arc Radiotherapy
por: Nien, Hsin-Hua, et al.
Publicado: (2023)

Low‐field MRI: Clinical promise and challenges
por: Arnold, Thomas Campbell, et al.
Publicado: (2022)

Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy
por: Yu, Yilin, et al.
Publicado: (2023)

The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
por: Bae, JuneSung, et al.
Publicado: (2022)

Methods, Challenges, and Promise of Next-Generation Sequencing in Cancer Biology
por: Haimovich, Adrian D.
Publicado: (2011)

Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
por: Abdalla, Ahmed M.E., et al.
Publicado: (2018)

EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
por: Janani, Balakarthikeyan, et al.
Publicado: (2022)

Application of single-cell genomics in cancer: promise and challenges
por: Wills, Quin F., et al.
Publicado: (2015)

The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi)
por: O'Meara, Wendy Prudhomme, et al.
Publicado: (2005)

Telepsychiatry: Promise, potential, and challenges
por: Malhotra, Savita, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iccqvd4nhbjn4pqs6avcijf832